Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population

Thomas Yau, Pierre Chan, Kelvin K. Ng, Sin Ho Chok, Tan To Cheung, Sheung Tat Fan, Ronnie T. Poon
  • Cancer, December 2008, Wiley
  • DOI: 10.1002/cncr.24029

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/cncr.24029

The following have contributed to this page: Professor Kenneth SH Chok